> The molecules are developed by research funding. Also incorrect. The underlying scientific knowledge driving new therapies is overwhelmingly academic in ori

> The molecules are developed by research funding. Also incorrect. The underlying scientific knowledge driving new therapies is overwhelmingly academic in origin, but academic research does very little actual drug discovery. I think the practice of university PR departments writing stories like "university professor discovers new cancer treatment" every time someone finds an effective in-vitro inhibitor has contributed to the confusion; most of these "drugs" never make it out of trials. Even for major advances like immuno-oncology and CRISPR that originated in academic labs, it takes many years of development (and hundreds of millions of dollars in private funding), most of which will not result in breathless press releases. There are many good arguments for changing the incentives and IP laws involved in biomedical science, but "academic labs will pick up the slack" is not one of them, and fundamentally misunderstands what academic institutions do well (or poorly).